𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of Hematopoiesis in Vitro with the Lym-1 Monoclonal Antibody

✍ Scribed by D. TUCK; M. SILVA; S. SORBA; A. GUHA; K. I. ABRAHAM; D. SCHOCHAT; N. DAINIAK

Book ID
119865586
Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
301 KB
Volume
628
Category
Article
ISSN
0890-6564

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of B cell malignancies with 13
Treatment of B cell malignancies with 131I LYM-1 monoclonal antibodies
✍ S. J. Denardo; G. L. Denardo; L. F. O'Grady; E. Hu; V. M. Sytsma; S. L. Mills; N πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 French βš– 689 KB

Lym-I is a murine IgG2, monoclonal antibody (MAb) that is B-cell specific but has greater avidity for malignant B cells when compared with normal B lymphocytes. It was originally produced by immunizing mice with nuclei of cultured cells from a patient with Burkitt's lymphoma. Ten patients with progr

Inhibition of HIV-1 infection in vitro b
Inhibition of HIV-1 infection in vitro by murine monoclonal anti-p24 antibodies
✍ L. Franke; R. Grunow; K. Meissner; T. Porstmann; R. von Baehr πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 572 KB

## Abstract Murine monoclonal antibodies (Mabs) to the major core protein p24 of the human immunodeficiency virus type 1 (HIV‐1) were tested for their ability to inhibit the replication and spread __of__ the virus in permanent cell cultures (Molt4/8, K37, H9) and in the culture of 11‐2 stimulated T

Radiopharmaceutical preparation of a mon
Radiopharmaceutical preparation of a monoclonal antibody, lym-1, and its F(ab')2 fragment for imaging lymphoma with In-111
✍ Stanley L. Mills; Sally J. Denardo; Gerald L. DeNardo; Shrikant V. Deshpande; Mi πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 500 KB

Lym-1) or its fragment F(ab')2 to produce two new radiopharmaceuticals. Immunoreactivity of the Lym-1, specific for B cell lymphoma, was not affected by the coupling reaction for 1.0 and 4.3 CITC molecules per whole antibody and 3.0 CITC molecules per F(ab')2 fragment. Both retained in excess of 90%